Researchers are currently experimenting in laboratories on the bioavailability of oral-buccal administration of peptide to the subcutaneous route, and results so far show that 1mg of peptide sublingually administered daily is equivalent to 5mg weekly subcutaneously. The research aims to suggest alternative methods for alleviating redness, pain, swelling, and total body chills, as well as muscular pain, triggered by subcutaneous administration in approximately 20% of the population. 

Please do not add this item to the shopping cart, as it is contract-manufactured upon order. Contact us for minimum quantity, bulk pricing, or packaging inquiries. MQTY runs from 140,000 to 1.64MM counts.